Advanced Search: 2nd Line

For more information about any of the clinical trials listed on this site, call 314-747-7222 or 800-600-3606 toll free or email Patient_Care_Coordination_Center@bjc.org.

Select Basic Search to view clinical trials grouped by category and Advanced Search to be able to further narrow search results.

 

201904214

IMPACT: Immunotherapy in Patients with Metastatic Cancers and CDK12 Mutations

201908065

A Parallel Arm Phase 1b/2a Study of DKN-01 as Monotherapy or in Combination With Docetaxel for the Treatment of Advanced Prostate Cancer

202006062

A Phase I and Randomized Phase II Trial of Radium-223 Dichloride, M3814, & Avelumab in Advanced Metastatic Castrate-Resistant Prostate Cancer (mCRPC) - 10301

202006013

Phase II Trial of pTVG-HP DNA Vaccine with or without pTVG-AR DNA Vaccine and Pembrolizumab in Patients with Castration-Resistant, Metastatic Prostate Cancer

202009203

A Phase 1 Study of FT-7051 in Men with Metastatic Castration-Resistant Prostate Cancer

202103170

SPLASH: Study Evaluating Metastatic Castrate Resistant ProstateCancer Treatment Using Lu-PNT2002 PSMA Therapy After Second-ilneHormonal Treatment

202102114

PSMAfore: A phase III, Open-label, Mulit-Center, Randomized Study Comparing 177Lu-PSMA-617 vs. a Change of androgen receptor-directed therapy in the Treatment of Taxane Naïve Men with Progressive Metastatic Castrate Resistant Prostate Cancer

202104068

A Phase 1b Study Evaluating the Safety, Tolerability, Pharmacokinetics and Efficacy of Delta-like Protein 3 Half-life Extended Bispecific T-cell Engager AMG 757 in Subjects with De Novo or Treatment Emergent Neuroendocrine Prostate Cancer